NANOSTRUCTURED DRUG MARKET ANALYSIS

Regional Analysis

Nanostructured Drug Market – Regional Insights

Based on the region, the global nanostructured drug treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds the dominant position in the global nanostructured drug market, owing to massive funding by the government for the nanotechnology research. For instance, According to a study led by Lux Research with funding support from U.S. national Foundation and U.S. National Nanotechnology Coordination Office in 2013, around US$ 1.9 billion was funded in 2011 and US$ 2.1 billion in 2012 for nanotechnology research and development (R&D). Moreover, increasing awareness among the population regarding various chronic diseases and well established healthcare infrastructure is expected to propel the nanostructured drug market growth over the forecast period.

Asia pacific is expected to gain significant market share in the nanostructured drug market, followed by Europe, owing to increasing number of population susceptible to various chronic diseases such cancer, HIV, and tuberculosis. For instance, according to the National Health and Family Planning Commission of the PRC report in 2015, around 533 out of 100,000 people died from chronic disease in 2012 in China, accounting for 86.6% of all deaths.